Skip to main content

Volume 3 Supplement 2

30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)

Epirubicin sequential natural killer cells enhanced the cytotoxicity to breast cancer cells in vitro

Background

Anthracycline-based chemotherapy is a conventional therapy for breast cancer patients, but also negatively affects host immune function. When the host immune system does not work, chemotherapy and radiotherapy cannot kill the cancer cells efficiently. Therefore, improve the host immune system is important for cancer efficient treatment. Meanwhile, natural killer (NK) cells are well known to boost the immune responses against cancer.

Methods

In this study, breast cancer cell lines were treated with anthracycline agent epirubicin (EPI) sequential with immune cells NK. NK cells in the study were amplified for 14 days in vitro from autologous adoptive cell transfer of breast cancer patients.

Results

The cytotoxicity of NK cells against breast cancer cells with 12 hr EPI (5.0 μg/ml) pre-treatment was significantly higher than untreated or EPI alone. Thus, EPI sequential NK cells show the synergistic cytotoxicity effects against breast cancer cells. Moreover, breast cancer cells show increased expression of NKG2D ligands (ULBP1, ULBP2 and MICA) after treatment of EPI. Additionally, EPI sequential NK cells secret more IFN-γ and TNF-α as well as the increased expression of perforin and Granzyme B.

Conclusions

Our findings reveal possible evidence for how to combine anthracycline-based chemotherapy with NK cells biotherapy to make a better treatment.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jingtao Chen.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Song, Y., Wang, Q., Feng, H. et al. Epirubicin sequential natural killer cells enhanced the cytotoxicity to breast cancer cells in vitro. j. immunotherapy cancer 3, P6 (2015). https://doi.org/10.1186/2051-1426-3-S2-P6

Download citation

Keywords

  • Breast Cancer
  • Breast Cancer Cell
  • Natural Killer
  • Breast Cancer Patient
  • Natural Killer Cell